Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice.

Li W, Hofer MJ, Noçon AL, Manders P, Campbell IL.

Virology. 2013 May 10;439(2):152-62. doi: 10.1016/j.virol.2013.02.015. Epub 2013 Mar 12.

2.

Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.

Zhou S, Cerny AM, Fitzgerald KA, Kurt-Jones EA, Finberg RW.

J Virol. 2012 Oct;86(20):11254-65. Epub 2012 Aug 8.

3.

IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.

Li W, Hofer MJ, Jung SR, Lim SL, Campbell IL.

J Virol. 2014 Jul;88(13):7578-88. doi: 10.1128/JVI.03117-13. Epub 2014 Apr 23.

4.

Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.

Hofer MJ, Li W, Manders P, Terry R, Lim SL, King NJ, Campbell IL.

J Virol. 2012 Jun;86(12):6932-46. doi: 10.1128/JVI.07147-11. Epub 2012 Apr 11.

5.

Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.

Lee MS, Park CH, Jeong YH, Kim YJ, Ha SJ.

PLoS Pathog. 2013;9(7):e1003478. doi: 10.1371/journal.ppat.1003478. Epub 2013 Jul 18.

6.

Differential impact of interferon regulatory factor 7 in initiation of the type I interferon response in the lymphocytic choriomeningitis virus-infected central nervous system versus the periphery.

Christensen JE, Fenger C, Issazadeh-Navikas S, Krug A, Liljestrøm P, Goriely S, Paludan SR, Finsen B, Christensen JP, Thomsen AR.

J Virol. 2012 Jul;86(13):7384-92. doi: 10.1128/JVI.07090-11. Epub 2012 Apr 18.

7.

A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.

Le Bon A, Montoya M, Edwards MJ, Thompson C, Burke SA, Ashton M, Lo D, Tough DF, Borrow P.

Eur J Immunol. 2006 Aug;36(8):2085-93.

10.

Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.

Binder D, van den Broek MF, Kägi D, Bluethmann H, Fehr J, Hengartner H, Zinkernagel RM.

J Exp Med. 1998 Jun 1;187(11):1903-20.

11.

The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.

Grujic M, Bartholdy C, Remy M, Pinschewer DD, Christensen JP, Thomsen AR.

J Immunol. 2010 Aug 1;185(3):1730-43. doi: 10.4049/jimmunol.0903894. Epub 2010 Jul 2.

13.
14.
15.
17.

Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion.

Kappes DJ, Lawrence DM, Vaughn MM, Davé VP, Belman AR, Rall GF.

Virology. 2000 Apr 10;269(2):248-56.

19.

Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models.

Audigé A, Hofer U, Dittmer U, van den Broek M, Speck RF.

Viral Immunol. 2011 Oct;24(5):375-85. doi: 10.1089/vim.2011.0006. Epub 2011 Sep 19.

PMID:
21929334
20.

Role of PKR and Type I IFNs in viral control during primary and secondary infection.

Nakayama Y, Plisch EH, Sullivan J, Thomas C, Czuprynski CJ, Williams BR, Suresh M.

PLoS Pathog. 2010 Jun 24;6(6):e1000966. doi: 10.1371/journal.ppat.1000966.

Items per page

Supplemental Content

Write to the Help Desk